Tobias Willer, PhD
Postdoctoral Scholar (2004-2009)
Director, Discovery Research and Gene Therapy Science, Amicus Therapeutics - Gene Therapy Center of Excellence
Biography
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A.S., Dobyns, W.B., Winder, T.L., Strahl, S., Mathews, K.D., Nelson, S.F., Moore, S.A. and Campbell, K.P. Nature Genetics, 44: 575-80, 2012. PMID: 22522420 PMCID: PMC3371168